We’re addressing two closely related but underserved markets: advanced upper-limb prosthetics and dexterous end effectors for humanoid robots. In prosthetics, the problem is access. Most bionic hands are either too expensive, too fragile, or too limited in functionality. In robotics, the challenge is time and cost. Humanoid companies need hands, but building them in-house is resource-heavy and slows time to market. We solve both by offering a modular, repairable, and affordable bionic hand platform that serves both markets without compromise.

May 2020 - Alt-Bionics was founded after Army Ranger Ryan Davis tested our first prototype, developed by our team at UTSA.
Aug. 2021 – Raised $215,000 in pre-seed funding to build IP, grow early prototypes, and expand social media presence.
Dec. 2022 – Built an organic social media following of 1.2M+, enabling CAC of <$10 through inbound interest.
Aug. 2023 – Raised $650,000 in seed capital to complete medical-grade prototypes, initiate clinical trials, and validate humanoid robotics applications.
Oct. 2023 – Signed LOI with Apptronik for 100 robotic hands, validating strong interest from tier 1 humanoid robotics companies.
Oct. 2023 – Non-provisional patents successfully issued for modular finger design and proportional force-sensing LED display.
Jun. 2024 – Closed $1.25M Seed+ round to scale production, expand the team, and go to market for both prosthetic and robotics products.
Jul. 2024 – Began fulfillment of early hand units to research labs and robotics companies for pilot integration and feedback.
Sep. 2024 – Debuted Genesis Hand at AOPA National Assembly, receiving strong interest from prosthetists and clinicians worldwide.
Nov. 2024 – Received PDAC approval for Genesis Hand, confirming reimbursement code eligibility (L6880 assigned).
Dec. 2024 – Debuted Surge Hand at the Humanoids Summit in Silicon Valley, resulting in sales to Nvidia and Ultra.
Jan. 2025 – Soft launched both bionic and robotic hand products.
Feb. 2025 – Officially partnered with Manus for teleoperation compatibility, becoming the only publicly named bionic hand partner; Manus supplies top-tier global tech and humanoid companies.
Apr. 2025 – Secured first international prosthetics distributor under contract targeting 100 units sold by end of year.

Q1 2025 – Generated $150,000 in early sales to Apptronik, Nvidia, Ultra, Shirley Ryan Ability Lab, Ukrainian clinics, and Egyptian clinics.
Q2 2025 – Began sales and early integration discussions with Unitree Spain, Unitree USA, Toyota, Samsung, Boston Dynamics, and other tier-1 humanoid robotics companies.